The company aims to raise its investment in biotechnology and biosimilars, focusing on an approximate current market value of USD 25 billion in India by 2025. Wockhardt's endeavours to scale up production abilities are obvious, with ideas to boost manufacturing capability by 30% more than the following two yrs. يمكنك https://wearethelist.com/story22164007/examine-this-report-on-lean